Anbuva Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 39.96 Cr
About Anbuva Pharma
Anbuva Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 April 2022 (Two years and nine months 20 days old ). Its registered office is in Mahesana, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹39.96 Cr.
Jagdish Chaudhary and Akshay Chaudhary serve as directors at the Company.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U21009GJ2022PTC130902
- Company No.
130902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Anbuva Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Chaudhary  | Director | 11-Apr-2022 | Current |
| Akshay Chaudhary | Director | 06-Mar-2024 | Current |
Financial Performance of Anbuva Pharma.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Anbuva Pharma?
Unlock access to Anbuva Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shankus Pharma Private LimitedJagdish Chaudhary is a mutual person
Keshav Holiday Resort Pvt LtdJagdish Chaudhary is a mutual person
Keshav Fertilizers Private LimitedJagdish Chaudhary is a mutual person
Shanku's Biosciences Private LimitedJagdish Chaudhary is a mutual person
Water White Oil Chem Private LimitedJagdish Chaudhary is a mutual person
- Neovant Therapeutics Private Limited
Jagdish Chaudhary is a mutual person
Charges (Loans)
₹399.60 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 39.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2024 | Hdfc Bank Limited | ₹39.96 Cr | Open |
How Many Employees Work at Anbuva Pharma?
Unlock and access historical data on people associated with Anbuva Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anbuva Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anbuva Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
